110941 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Metapneumovirus, e.g. avian pneumovirus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
BETACORONAVIRUS mRNA VACCINES
#2BETACORONAVIRUS mRNA VACCINES
#3IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#4RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE
#5VACCINE AGAINST INFECTIOUS BRONCHITIS
#6VACCINE COMPOSITION AGAINST TWO RESPIRATORY VIRUSES
#7MULTIVALENT VACCINE FOR PARAMYXOVIRUSES AND USES THEREOF
#8PAN-PNEUMOVIRUS VACCINE COMPOSITIONS AND METHODS OF USE THEREOF
#9BETACORONA VIRUS mRNA VACCINES
#10BETACORONAVIRUS mRNA VACCINES
#11HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES
#12COMBINATION HMPV/RSV RNA VACCINES
#13Betacoronavirus RNA vaccines
#14COMBINATION HMPV/RSV RNA VACCINES
#15COMBINATION HMPV/RSV RNA VACCINES
#16ANTIBODIES THAT BIND METAPNEUMOVIRUS, ANTIGENIC METAPNEUMOVIRUS PROTEINS, AND USES THEREOF
#17Respiratory syncytial virus mRNA vaccine
#18RESPIRATORY VIRUS COMBINATION VACCINES
#19HUMAN METAPNEUMO VIRUS VACCINE
#20Recombinant metapneumovirus f proteins and their use
#21RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE
#22Vaccine against infectious bronchitis
#23MULTI-RESPIRATORY VIRUS ANTIGEN-SPECIFIC T CELLS AND METHODS OF MAKING AND USING THE SAME THERAPEUTICALLY
#24PRODUCTION OF VIRAL VACCINES ON AN AVIAN CELL LINE
#25Recombinant metapneumovirus F proteins and their use
#26Method for rescuing and producing a virus in avian cells
#27Combination HMPV/RSV RNA vaccines
#28Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#29Betacoronavirus mRNA vaccine
#30Betacoronavirus mRNA vaccine
#31Virus causing respiratory tract illness in susceptible mammals
#32Respiratory virus nucleic acid vaccines
#33Recombinant metapneumovirus F proteins and their use
#34HPIV3 RNA vaccines
#35Vaccine against infectious bronchitis
#36hMPV RNA vaccines
#37Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof
#38Virus causing respiratory tract illness in susceptible mammals
#39Human respiratory syncytial virus (HRSV) virus-like particles (VLPS) based vaccine
#40Combination PIV3/hMPV RNA vaccines
#41Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#42Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#43Virus causing respiratory tract illness in susceptible mammals
#44Recombinant metapneumovirus F proteins and their use
#45Virus causing respiratory tract illness in susceptible mammals
#46strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#47Virus causing respiratory tract illness in susceptible mammals
#48Immunogenic formulation containing recombinant live BCG that express antigens of metapneumovirus (hMPV), in a suspension prepared from a lyophilisate, without requiring an adjuvant, suitable for pharmaceutical use
#49immunogens and related materials and methods
#50Virus causing respiratory tract illness in susceptible mammals
#51Paramyxovirus immunogens and related materials and methods
#52Alphavirus vectors for respiratory pathogen vaccines
#53Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#54Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#55Immunostimulatory oligodeoxynucleotides
#56Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
#57Vaccine
#58RECOMBINANT PARAINFLUENZA VIRUS VACCINE COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM RESPIRATORY SYNCYTIAL VIRUS
#59Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
#60Alphavirus Vectors for Respiratory Pathogen Vaccines
#61Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
#62Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals
#63Method of treating pregnant cows and/or heifers
#64METAPNEUMOVIRUS STRAINS AND THEIR USE IN VACCINE FORMULATIONS AND AS VECTORS FOR EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS FOR PROPAGATING VIRUS
#65Metapneumovirus strains and their use in vaccine formulations and sequences
#66VACCINE FOR IN OVO INOCULATION
#67Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#68Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#69VACCINE DELIVERY SYSTEM
#70Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
#71VACCINE FOR RSV AND MPV
#72NUCLEIC ACID IMMUNOLOGICAL COMPOSITION FOR HUMAN METAPNEUMOVIRUS
#73Alphavirus Vectors for Respiratory Pathogen Vaccines
#74Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
#75Sustained release vaccine composition
#76Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#77Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor
#78Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
#79Methods and vaccines for providing in ovo protection against turkey rhinotracheitis
#80Attenuation of metapneumovirus
#81Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
#82Virus causing respiratory tract illness in susceptible mammals
#83Virus causing respiratory tract illness in susceptible mammals
#84Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus